Results 131 to 140 of about 25,087 (209)

Accelerated Chronic Lymphocytic Leukaemia Complicated by Bilateral Pathological Humeral Fractures

eJHaem, Volume 7, Issue 1, February 2026.
Mariyum Khawar, Varvara Bashkirova, Vidhya Manohar, Jaymathi Dhanapal   +3 more
wiley   +1 more source

DDX41-Mutated AML: A Case Report and Perspectives. [PDF]

JCO Precis Oncol
Yashar WM, Eide CA, Kurtz SE, Long N, Johnson KJ, Tognon CE, Druker BJ, Tyner JW, Swords R.   +8 more
europepmc   +1 more source

Venetoclax induces mitochondrial apoptosis and autophagy to overcome arsenic trioxide resistance in acute promyelocytic leukemia. [PDF]

J Transl Med
Dutta D, Maity A, Gupta SK, Gera P, Jain H, Bagal B, Chatterjee G, Rajpal S, Nayak L, Punatar S, Bandyopadhyay S, Chakraborty A, Chendamarai E, Balasundaram N, Gota V, Khattry N, Sengar M, Mathews V, Hasan SK.   +18 more
europepmc   +1 more source

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy [PDF]

, 2018
Coats, Josh, Collins, Graham P., Cross, Matthew, Dyer, Martin J. S., Eyre, Toby A., Follows, George, Fox, Christopher P., Hodson, Andrew, Iyengar, Sunil, Morley, Nick, Narat, Santosh, Walter, Harriet S.   +11 more
core   +3 more sources

The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir. [PDF]

PLoS Pathog
Kim Y, Anderson JL, Tumpach C, Solomon A, Ong J, Tanaka K, Zerbato JM, Tan T, Teh CE, Gray DHD, Arandjelovic P, McMahon J, Meagher N, Price D, Pellegrini M, Roche M, Lewin SR.   +16 more
europepmc   +1 more source

The use of venetoclax in the treatment of acute lymphoblastic leukemia-a systematic review. [PDF]

Ther Adv Med Oncol
Kowalczyk A, Zarychta J, Zawitkowska J, Lejman M.   +3 more
europepmc   +1 more source

Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia [PDF]

, 2017
C. J. Owen, C. L. Toze, C. Shustik, I. Bence-Bruckler, R. Delage, S. Coutre   +5 more
core   +1 more source

CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in lymphoid malignancies. [PDF]

J Hematol Oncol
Chong SJF, Valentin R, Wang J, Zhu F, Gokhale PC, Eschle BK, Garbicz F, Iskandar K, Sewastianik T, Toh BCY, Penailillo J, Peluso MO, Zhang J, Hackett L, Collins MC, Lehmberg TZ, Adam A, Zhang L, Armet CM, Rausch M, Lee BH, Holland PM, Palombella VJ, Paterson AM, Kong LR, Ten Hacken E, Guerriero JL, Herbaux C, Wu CJ, Chng WJ, Pervaiz S, Niemann CU, Carrasco RD, Davids MS.   +33 more
europepmc   +1 more source

Mini-hyper-CVD plus venetoclax and navitoclax for relapsed/refractory acute lymphoblastic leukemia. [PDF]

Blood Adv
Short NJ, Kantarjian H, Jain N, Kadia TM, Senapati J, Haddad FG, Maroun MM, Sasaki K, Xiao L, Huang X, Karrar O, Abramova R, Zhao M, Garris R, Konopleva M, Ravandi F, Jabbour E.   +16 more
europepmc   +1 more source

Milestones in Chronic Lymphocytic Leukemia [PDF]

, 2017

core   +1 more source